Azitra, Inc. (AZTR)
Automate Your Wheel Strategy on AZTR
With Tiblio's Option Bot, you can configure your own wheel strategy including AZTR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol AZTR
- Rev/Share 3.0652
- Book/Share 911.8756
- PB 0.0008
- Debt/Equity 0.2592
- CurrentRatio 1.2391
- ROIC -3.9136
- MktCap 2544257.0
- FreeCF/Share -1259.9915
- PFCF -0.0008
- PE -0.0006
- Debt/Assets 0.1461
- DivYield 0
- ROE -5.473
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 5
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Azitra, Inc. Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash
Published: August 27, 2025 by: PRNewsWire
Sentiment: Neutral
BRANFORD, Conn., Aug. 27, 2025 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced the dosing of the first patient in its Phase 1/2 clinical trial of ATR04-484, a topically applied live biotherapeutic product candidate designed to treat EGFR inhibitor ("EGFRi")-associated rash.
Read More
Stock Market Today: Nasdaq, Dow, S&P 500 Futures Rise Ahead Of Powell's Speech At Jackson Hole—EpicQuest, Zoom, Azitra Stocks In Focus
Published: August 22, 2025 by: Benzinga
Sentiment: Positive
U.S. stock futures rose on Friday following Thursday's declines. Futures of major benchmark indices were higher.
Read More
About Azitra, Inc. (AZTR)
- IPO Date 2023-06-20
- Website https://azitrainc.com
- Industry Biotechnology
- CEO Francisco D. Salva
- Employees 12